By Kathryn Hardison

Moderna Inc. said Tuesday that its respiratory syncytial virus vaccine significantly reduced the risk of a viral respiratory disease among older adults in a large clinical trial. Shares increased 5.6% in after-hours trading.

SmileDirectClub Inc. said it will realign its operating programs and global workforce as it targets costs. The strategy should result in an additional $120 million to $140 million in savings this year, excluding transition costs, the oral care company said. Shares gained 13% in after-hours trading.

Big 5 Sporting Goods Corp. reported fourth-quarter sales near the low end of its prior guidance as inflation curbed holiday discretionary spending. Shares declined 7.7% in after-hours trading.

Arcimoto Inc. plans a stock offering and intends to use proceeds for working capital and other general corporate purposes. Shares dropped 32% in after-hours trading.

Write to Kathryn Hardison at kathryn.hardison@wsj.com

(END) Dow Jones Newswires

January 17, 2023 19:01 ET (00:01 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Moderna (NASDAQ:MRNA)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024 Click aqui para mais gráficos Moderna.
Moderna (NASDAQ:MRNA)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024 Click aqui para mais gráficos Moderna.